Patent · US Expired

Anti-tumor compositions containing the reactive product of benzaldehyde or salicylaldehyde with penicillamine and method of use thereof

US5169858A · kind A · utility

28Cited by
1References
14Claims
0Family size

Inventor

Key dates

Filing dateFeb 26, 1986
Grant dateDec 8, 1992
Priority date
Expiry dateFeb 26, 2006

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K31/425
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A composition for therapy of tumors having high tyrosinase activity contains the reaction product of penicillamine with a cytotoxic aldehyde, or pharmaceutically acceptable salts or esters thereof, and a pharmaceutically acceptable vehicle. The preferred compounds are 5,5-dimethyl-2-phenyl-4-thiazolidine carboxylic acid or 5,5-dimethyl-2-(2-hydroxyphenyl)-4-thiazolidine carboxylic acid, or pharmaceutically acceptable salts or esters thereof. Treatment preferably comprises an intra-arterial drip. Diagnosis of tumors suitable for treatment by means of these compositions may be accomplished by administering a radioactive copper salt and scanning for accumulations of radioactivity. This will indicate sites of high tyrosinase activity.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.